BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27488535)

  • 21. Expression of insulin-like growth factor pathway proteins in rhabdomyosarcoma: IGF-2 expression is associated with translocation-negative tumors.
    Makawita S; Ho M; Durbin AD; Thorner PS; Malkin D; Somers GR
    Pediatr Dev Pathol; 2009; 12(2):127-35. PubMed ID: 18788888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fusion transcriptome profiling provides insights into alveolar rhabdomyosarcoma.
    Xie Z; Babiceanu M; Kumar S; Jia Y; Qin F; Barr FG; Li H
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13126-13131. PubMed ID: 27799565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uncovering metabolism in rhabdomyosarcoma.
    Monti E; Fanzani A
    Cell Cycle; 2016; 15(2):184-95. PubMed ID: 26209235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quercetin and tin protoporphyrin attenuate hepatic ischemia reperfusion injury: role of HO-1.
    Atef Y; El-Fayoumi HM; Abdel-Mottaleb Y; Mahmoud MF
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):871-881. PubMed ID: 28589248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma.
    Ahn EH
    Anticancer Res; 2013 May; 33(5):2029-35. PubMed ID: 23645752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RGD liposome-protamine-siRNA (LPR) nanoparticles targeting PAX3-FOXO1 for alveolar rhabdomyosarcoma therapy.
    Rengaswamy V; Zimmer D; Süss R; Rössler J
    J Control Release; 2016 Aug; 235():319-327. PubMed ID: 27261335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of heme oxygenase 1 modulation on the progression of murine collagen-induced arthritis.
    Devesa I; Ferrándiz ML; Terencio MC; Joosten LA; van den Berg WB; Alcaraz MJ
    Arthritis Rheum; 2005 Oct; 52(10):3230-8. PubMed ID: 16200597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SNAIL is a key regulator of alveolar rhabdomyosarcoma tumor growth and differentiation through repression of MYF5 and MYOD function.
    Skrzypek K; Kusienicka A; Trzyna E; Szewczyk B; Ulman A; Konieczny P; Adamus T; Badyra B; Kortylewski M; Majka M
    Cell Death Dis; 2018 May; 9(6):643. PubMed ID: 29844345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of heme oxygenase-1 contributes to survival of Mycobacterium abscessus in human macrophages-like THP-1 cells.
    Abdalla MY; Ahmad IM; Switzer B; Britigan BE
    Redox Biol; 2015; 4():328-39. PubMed ID: 25638774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma.
    Li L; Sarver AL; Alamgir S; Subramanian S
    Lab Invest; 2012 Apr; 92(4):571-83. PubMed ID: 22330340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcoma.
    Ghayad SE; Rammal G; Sarkis O; Basma H; Ghamloush F; Fahs A; Karam M; Harajli M; Rabeh W; Mouawad JE; Zalzali H; Saab R
    Cancer Biol Ther; 2019; 20(3):272-283. PubMed ID: 30307360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cobalt protoporphyrin induces HO-1 expression mediated partially by FOXO1 and reduces mitochondria-derived reactive oxygen species production.
    Liu X; Cui Y; Li M; Xu H; Zuo J; Fang F; Chang Y
    PLoS One; 2013; 8(11):e80521. PubMed ID: 24255720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High IGFBP2 expression correlates with tumor severity in pediatric rhabdomyosarcoma.
    Tombolan L; Orso F; Guzzardo V; Casara S; Zin A; Bonora M; Romualdi C; Giorgi C; Bisogno G; Alaggio R; Pinton P; De Pittà C; Taverna D; Rosolen A; Lanfranchi G
    Am J Pathol; 2011 Nov; 179(5):2611-24. PubMed ID: 21924226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation.
    Taulli R; Bersani F; Foglizzo V; Linari A; Vigna E; Ladanyi M; Tuschl T; Ponzetto C
    J Clin Invest; 2009 Aug; 119(8):2366-78. PubMed ID: 19620785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of PAX3/7-FOXO1 fusion status in alveolar rhabdomyosarcoma: Systematic review and meta-analysis.
    Kubo T; Shimose S; Fujimori J; Furuta T; Ochi M
    Crit Rev Oncol Hematol; 2015 Oct; 96(1):46-53. PubMed ID: 26008753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members.
    Megiorni F; Cialfi S; McDowell HP; Felsani A; Camero S; Guffanti A; Pizer B; Clerico A; De Grazia A; Pizzuti A; Moles A; Dominici C
    BMC Cancer; 2014 Nov; 14():880. PubMed ID: 25427715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas.
    Laé M; Ahn EH; Mercado GE; Chuai S; Edgar M; Pawel BR; Olshen A; Barr FG; Ladanyi M
    J Pathol; 2007 Jun; 212(2):143-51. PubMed ID: 17471488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical rationale for entinostat in embryonal rhabdomyosarcoma.
    Bharathy N; Berlow NE; Wang E; Abraham J; Settelmeyer TP; Hooper JE; Svalina MN; Bajwa Z; Goros MW; Hernandez BS; Wolff JE; Pal R; Davies AM; Ashok A; Bushby D; Mancini M; Noakes C; Goodwin NC; Ordentlich P; Keck J; Hawkins DS; Rudzinski ER; Mansoor A; Perkins TJ; Vakoc CR; Michalek JE; Keller C
    Skelet Muscle; 2019 May; 9(1):12. PubMed ID: 31113472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification.
    Missiaglia E; Williamson D; Chisholm J; Wirapati P; Pierron G; Petel F; Concordet JP; Thway K; Oberlin O; Pritchard-Jones K; Delattre O; Delorenzi M; Shipley J
    J Clin Oncol; 2012 May; 30(14):1670-7. PubMed ID: 22454413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular biology of rhabdomyosarcoma.
    Gallego Melcón S; Sánchez de Toledo Codina J
    Clin Transl Oncol; 2007 Jul; 9(7):415-9. PubMed ID: 17652054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.